馬獸醫治療市場－全球產業規模、佔有率、趨勢、機會和預測，按藥物、給藥途徑、配銷通路、地區和競爭格局分類，2020-2030年預測

2024年全球馬匹獸藥市場規模為18.2億美元，預計2030年將以7.21%的複合年成長率成長至27.6億美元。該市場涵蓋專門用於維護和恢復馬匹健康的藥品、疫苗和診斷工具。推動市場成長的主要因素包括：各種馬匹疾病的日益普遍、馬主對動物福利和預防保健意識的提高，以及馬術運動在全球範圍內的持續發展。

主要市場促進因素

人們對馬匹健康意識的提高和預防性護理的日益普及，顯著推動了全球馬匹獸藥市場的發展。馬主們越來越認知到積極主動的健康管理帶來的長期益處，從而導致對疫苗、驅蟲藥和營養補充劑的需求增加。

主要市場挑戰

熟練的馬獸醫持續短缺，嚴重阻礙了全球馬獸醫治療市場的擴張。從業人員數量有限，直接限制了基本獸醫服務的可近性，包括常規健康檢查、疾病診斷以及關鍵藥物和疫苗的接種。

主要市場趨勢

向個人化馬匹治療方案的轉變代表著一個重要的發展，它超越了標準化的治療方案，轉而關注每匹馬獨特的生理和遺傳特徵。這種方法利用包括基因檢測在內的先進診斷技術，為有針對性的治療介入提供基礎。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球馬獸藥市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依藥物分類（抗發炎藥、抗感染藥、殺寄生蟲藥、其他）
  • 依給藥途徑（口服、注射、外用）
  • 按配銷通路（獸醫院、獸醫診所、藥房、電子商務、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美馬獸藥市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲馬獸藥市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區馬獸藥市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲馬獸藥市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲馬獸藥市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球馬獸藥市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Merck & Co., Inc.
• Thermo Fisher Scientific Inc (Affymetrix)
• Elanco Animal Health Inc.
• Zoetis Services LLC
• Farnam Companies, Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Equine Veterinary Therapeutics Market, valued at USD 1.82 Billion in 2024, is projected to experience a CAGR of 7.21% to reach USD 2.76 Billion by 2030. The Global Equine Veterinary Therapeutics Market encompasses pharmaceuticals, vaccines, and diagnostic tools specifically developed to maintain and restore the health of horses. This market's growth is primarily driven by the increasing prevalence of various equine diseases, a heightened awareness among horse owners regarding animal welfare and preventive care, and the sustained expansion of equestrian sports globally.

Key Market Drivers

Increased equine health awareness and the rising adoption of preventative care significantly drive the global equine veterinary therapeutics market. Horse owners are increasingly recognizing the long-term benefits of proactive health management, leading to greater demand for vaccines, parasiticides, and nutritional supplements. This shift towards preventative strategies minimizes the incidence and severity of diseases, thereby necessitating a steady supply of efficacious therapeutics for routine immunization and health maintenance.

Key Market Challenges

The persistent shortage of skilled equine veterinarians represents a significant impediment to the expansion of the Global Equine Veterinary Therapeutics Market. A limited number of practitioners directly restricts the accessibility of essential veterinary services, including routine health examinations, disease diagnosis, and the administration of critical pharmaceuticals and vaccines. This constraint means that even with advanced therapeutics available, their deployment to the substantial equine population is bottlenecked by the human resources required for delivery and oversight.

Key Market Trends

The shift towards personalized equine treatment plans represents a critical evolution, moving beyond standardized protocols to cater to the individual physiological and genetic makeup of each horse. This approach leverages advanced diagnostics, including genetic testing, to inform targeted therapeutic interventions.

Key Market Players

• Merck & Co., Inc.
• Thermo Fisher Scientific Inc (Affymetrix)
• Elanco Animal Health Inc.
• Zoetis Services LLC
• Farnam Companies, Inc.

Report Scope:

In this report, the Global Equine Veterinary Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Veterinary Therapeutics Market, By Drugs:

• Anti-Inflammatory
• Anti-Infective
• Parasiticides
• Others

Equine Veterinary Therapeutics Market, By Route of Administration:

• Oral
• Parental
• Topical

Equine Veterinary Therapeutics Market, By Distribution Channel:

• Veterinary Hospital
• Veterinary Clinics
• Pharmacies and drugstores
• E-commerce
• Other

Equine Veterinary Therapeutics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Equine Veterinary Therapeutics Market.

Available Customizations:

Global Equine Veterinary Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Veterinary Therapeutics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drugs (Anti-Inflammatory, Anti-Infective, Parasiticides, Others)
  • 5.2.2. By Route of Administration (Oral, Parental, Topical)
  • 5.2.3. By Distribution Channel (Veterinary Hospital, Veterinary Clinics, Pharmacies and drugstores, E-commerce, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Equine Veterinary Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drugs
  • 6.2.2. By Route of Administration
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Veterinary Therapeutics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drugs
      • 6.3.1.2.2. By Route of Administration
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Equine Veterinary Therapeutics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drugs
      • 6.3.2.2.2. By Route of Administration
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Equine Veterinary Therapeutics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drugs
      • 6.3.3.2.2. By Route of Administration
      • 6.3.3.2.3. By Distribution Channel

7. Europe Equine Veterinary Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drugs
  • 7.2.2. By Route of Administration
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Equine Veterinary Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drugs
      • 7.3.1.2.2. By Route of Administration
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Equine Veterinary Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drugs
      • 7.3.2.2.2. By Route of Administration
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Equine Veterinary Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drugs
      • 7.3.3.2.2. By Route of Administration
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Equine Veterinary Therapeutics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drugs
      • 7.3.4.2.2. By Route of Administration
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Equine Veterinary Therapeutics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drugs
      • 7.3.5.2.2. By Route of Administration
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Equine Veterinary Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drugs
  • 8.2.2. By Route of Administration
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Equine Veterinary Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drugs
      • 8.3.1.2.2. By Route of Administration
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Equine Veterinary Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drugs
      • 8.3.2.2.2. By Route of Administration
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Equine Veterinary Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drugs
      • 8.3.3.2.2. By Route of Administration
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Equine Veterinary Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drugs
      • 8.3.4.2.2. By Route of Administration
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Equine Veterinary Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drugs
      • 8.3.5.2.2. By Route of Administration
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Equine Veterinary Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drugs
  • 9.2.2. By Route of Administration
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Equine Veterinary Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drugs
      • 9.3.1.2.2. By Route of Administration
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Equine Veterinary Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drugs
      • 9.3.2.2.2. By Route of Administration
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Equine Veterinary Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drugs
      • 9.3.3.2.2. By Route of Administration
      • 9.3.3.2.3. By Distribution Channel

10. South America Equine Veterinary Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drugs
  • 10.2.2. By Route of Administration
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Equine Veterinary Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drugs
      • 10.3.1.2.2. By Route of Administration
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Equine Veterinary Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drugs
      • 10.3.2.2.2. By Route of Administration
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Equine Veterinary Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drugs
      • 10.3.3.2.2. By Route of Administration
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Equine Veterinary Therapeutics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck & Co., Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc (Affymetrix)
• 15.3. Elanco Animal Health Inc.
• 15.4. Zoetis Services LLC
• 15.5. Farnam Companies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer